molecule

Filter Vial Compound

Compatibility Index

Thomson Filter Vials are designed for small-volume sterilization and clarification of pharmacy solutions for analytical analysis. Please search the index below to find the Filter Vial suitable to your needs.

Filter to be used PVDF
.2μM		 PES
.2μM		 PTFE
.2μM		 PES
.45μM		 PVDF
.45μM		 Cross Reference Article
Drug Name 35531 35535 35530 35545 35541  
5-Fluorouracil     green cap     30,31
(18F) Fluoromisondazole, Misiomidazole red cap         5
Acebutolol   gray cap       12
Acetylsalicylic acid   gray cap       12
Alpha1-Proteinase Inhibitor (Human)         yellow cap 28
Alprenolol   gray cap       12
Amiloride   gray cap       12
Amphotericin B for Injection USP         yellow cap 14,21,24,32,37
Atenolol   gray cap       12
Azathioprine       orange cap yellow cap 35
Azodicarbonamide   gray cap       6
Bleomycin Sulfate     green cap     30,31
Caffeine   gray cap       12
Cetirizine       orange cap yellow cap 34
Chlorothiazide   gray cap       12
Chloramphenicol   gray cap       12
Cimetidine   gray cap       12
Ciprofloxacin   gray cap       29
Cisplatin, Cisplatin Injection     green cap     30,31
Filter to be used PVDF
.2μM		 PES
.2μM		 PTFE
.2μM		 PES
.45μM		 PVDF
.45μM		 Cross Reference Article
Drug Name 35531 35535 35530 35545 35541  
Cyclosporine A red cap         10
Cytarabine     green cap     30
Daunorubicin     green cap     2,30,31
DE-310   gray cap       27
Diclofenac         yellow cap 1
Enalapril   gray cap       12
Ethionamide     green cap     17
Factor IX Complex Heat-Treated         yellow cap 28
Gatifloxacin       orange cap yellow cap 22
Hydrochlorothiazide   gray cap       12
Ibuprofen       orange cap yellow cap 1
Iosniazid     green cap     17
isonicotinic acid     green cap     17
Ketamine   gray cap       26
Las 35917         yellow cap 15
Levofloxacin       orange cap yellow cap 22
Lomefloxacin       orange cap yellow cap 22
Methyl Gag; NSC-32946     green cap     30,31
Metoprolol   gray cap       12
Filter to be used PVDF
.2μM		 PES
.2μM		 PTFE
.2μM		 PES
.45μM		 PVDF
.45μM		 Cross Reference Article
Drug Name 35531 35535 35530 35545 35541  
Mitomycin     green cap     30,31
Morphazinamide     green cap     17
Nadolol   gray cap       12
Nicotinic acid     green cap     17
Paclitaxel red cap         7
p-Aminobenzoic acid (PABA)         yellow cap 1
p-aminosalicylic acid     green cap     17
Pefloxacin       orange cap yellow cap 22
Pentoxifylline (PTX) red cap         23
Phenytoin         yellow cap 33
Pyrazinamide     green cap     17
Pyrimethamine       orange cap yellow cap 20
Ranitidine   gray cap       12
Rifampicin       orange cap yellow cap 16
Sabeluzole         yellow cap 11
Streptokinase         yellow cap 24
Sulfadozine         yellow cap 20
Sulphasalazine   gray cap       12
Sulpiride   gray cap       12
Filter to be used PVDF
.2μM		 PES
.2μM		 PTFE
.2μM		 PES
.45μM		 PVDF
.45μM		 Cross Reference Article
Drug Name 35531 35535 35530 35545 35541  
Terbutaline   gray cap       12
Thiotepa Parenteral Sterile     green cap     30,31
Timolol   gray cap       12
Tobramycin Vincristine Sulfate     green cap     4,8,9,13,18,19,30,31,36
Tranexamic acid   gray cap       12
Triamcinolone Acetonide   gray cap       25
Triazinate; NSC-139105     green cap     30
Tropicamide       orange cap   3
Vinblastine Sulfate     green cap     30,31
Thomson Part # 35531 35535 35530 35545 35541  

References

  1. Santini, A. O. et al. (2004). p-Aminobenzoate ion determination in pharmaceutical formulations by using a potentiometric sensor immobilized in a graphite matrix. Talanta 63:833-838.
  2. Bosanquet, A.G. (1985) Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. General considerations, the nitrosoureas and alkylating agents. Cancer Chemother. Pharmacol. 14:83-95
  3. Capello, B. et al. (2001) Solubilization of tropicamide by hydroxypropyl-[beta]-cyclodextrin and water-soluable polymers: in vitro/in vivo studies. Int. J. Pharm.213:75-81.
  4. Butler, L.D., et al (1980). Effect of inline filtration on the potency of low-dose drugs. Am. J. Hosp. Pharm. 37:935-941.
  5. Chang, C.W., et al.(2007). A robotic synthesis of [18F]fluoromisonidazole([18F]FMISO), Applied Radiation and Isotopes, In Press, Accepted Manuscript, Available online 6 February.
  6. Fagny, C., et al. (2002). Ribonucleotide reductase and thymidine phosphorylation: two potential targets of azodicarbonamide. Biochem. Pharmacol. 64: 451-456.
  7. et al. (2003). Fluoro-, bromo-, iodopaclitaxel derivatives: synthesis and biological evaluation. Nuclear Medicine and Biology. 30: 11-24.
  8. Elenbaas, J.K., et al. (1985). Effect of inline filtration on tobramycin delivery. Drug Intell. Clin. Pharm. 19: 122-125.
  9. Ennis, C.E., et al. (1983) In vitro study of inline filtration of medications commonly administered to pediatric cancer patients. J. Parenter Enter.Nutr. 7: 156-158.
  10. Lallemand, et. al. (2005) A novel water-soluble cyclosporine A prodrug: Ocular tolerance and in vivo kinetics. Int.J.Pharm. 295: 7-14.
  11. Verreck, G., et al. (2005). Preparation and physicochemical characterization of biodegradable nerve guides containing the nerve growth agent sabeluzole. Biomaterials 26: 1307-1315.
  12. Flaten, G.E., et al. (2006) Drug permeability across a phospholipid vesicle based barrier. A novel approach for studying passive diffusion. European Journal of Pharmaceutical Sciences 27: 80-90.
  13. Grant, A.M.(1987). Personal communication.
  14. Huber, R.C. and Riffkin, C. (1975) Inline final filters for removing particles from amphotericin B infusions. Am.J.Hosp.Pharm. 32: 173-176.
  15. Toro, I. et al. (2004). Development and validation of a capillary electrophoresis method with ultraviolet detection for the determination of the related substances in a pharmaceutical compound. J. Chromatogr. A 1043: 303-315
  16. Calleja, I. et al. (2004). High–performance liquid-chromatographic determination of rifampicin in plasma and tissues. J. Chromatogr. 1031: 289-294.
  17. Gennaro, M.C., et al. (2001) Ion interaction reagent reversed-phase high-performance liquid chromatography determination of anti-tuberculosis drugs and metabolites in biological fluids. J. Chromatogr. B 754: 477-486.
  18. Kanke, M., et al. (1983). Binding of selected drugs to a “treated” inline filter. Am. J. Hosp.Pharm. 40: 1323-1328.
  19. Khue, N. V., and Jung, L. (1985). Study of the retention of child-dose drugs on cellulose ester membranes during inline intravenous filtration. S-T-P Pharma. 1: 201-207.
  20. Boca, M.B., et al. (2005), A validated HPLC method for determining residues of a dual active ingredient anti-malarial drug on manufacturing equipment surfaces. J. Pharm. Biomed.Anal. 37:461-468.
  21. Maddus, M.S. , and Barrierre, S.L. (1980). A review of complications of amphotericin B therapy; recommendations for prevention and management. Drug Intell. Clin. Pharm. 14: 177-181.
  22. Ines, M., et al. (2006). Quantitative determination of gatifloxacin, levofloxacin, lomefloxacin and pefloxacin fluoroquinolonic antibodies in pharmaceutical preparations by high-performance liquid chromatography. J. Pharm.Biomed.Anal. 40: 179-184.
  23. Fantin, M., et al. (2006). Pentoxifylline and its major oxidative metabolites exhibit different pharmacological properties. European Journal of Pharmacology 535: 301-309.
  24. McEvoy, G. K. (Ed.) . (1991) American hospital formulary service drug information 91. American Society of Hospital Pharmacists.
  25. Ober, M.D. et al. (2006), Measurement of the Actual Dose of Triamcinolone Acetonide Delivered by Common Techniques of Intravitreal Injection. American Journal of Ophthalmology 142: 597-600.e1.
  26. Lofwall, M. R. ,et al. (2006). Cognitive and Subjective Acute Dose Effects of Intramuscular Ketamine in Healthy Adults. Experimental and Clinical Psychopharmacology 14: 439-449.
  27. Kato, M., et al. (2005) Examination of meningocele induced by the antitumor agent DE-310 in rat fetuses. Reproductive Toxicology 20: 495-502.28. Miles Pharm.
  28. Langer, O., et al. (2003). Synthesis of fluorine-18-labeled ciprofloxacin for PET studies in humans. Nuclear Medicine and Biology 30: 285-291.
  29. Pavlik, E. J., et al. (198e). Properties of anticancer agents relevant to in vitro determinations of human tumor cell sensitivity. Cancer Chemother. Pharmacol. 11: 8-15.
  30. Pavlik, E.J., et al. (1982) Sensitivity to anticancer agents in vitro: standardizing the cytotoxic response and characterizing the sensitivities of a reference cell line. Gynecol. Oncol. 14: 243-261.
  31. Oradell, N.J., 1991). Physicians’ Desk Reference. 45th edition.
  32. Rusmin, S., et al. (1977). Effect of inline filtration on the potency of drugs administered intravenously. Am.J. Hosp. Pharm. 34: 1071-1074.
  33. Rudaz, S., et al. (2003). Veuthey, Development and validation of a heart-cutting liquid chromatography-mass spectrometry method for the determination of process-related substances in cetirizine tablets. Analytica Chimica Acta 492: 271-282.
  34. Fazio, T.T., et al. (2007) Quantitative determination and sampling of azathioprine residues for cleaning validation in production area. J. Pharm. Biomed,Anal. 43: 1495-1498.
  35. Thompson, D. F., et al. (1984). Effect of inline filtration on pediatric doses of gentamicin and tobramycin. Infusion 8: 31-32.
  36. Tipple, M. et al. (1977). Availability of active amphotericin B after filtration through membrane filters. Am. Rev. Resp.Dis 115: 879-881.
back to top

Compound Index Navigation

Use the links below to navigate to the compound of interest.

Back To Technical Library
back to top